Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

BACKGROUND: Cervical cancer is now considered the second leading cause of death among women worldwide, and its incidence has reached alarming levels, especially in developing countries. Similarly, high grade squamous intraepithelial lesion (HSIL), the precursor stage for cervical cancer, represents...

詳細記述

保存先:
書誌詳細
主要な著者: Solares, Ana M, Santana, Agueda, Baladrón, Idania, Valenzuela, Carmen, González, Carlos A, Díaz, Alina, Castillo, Dagnelia, Ramos, Thelvia, Gómez, Roberto, Alonso, Daniel F, Herrera, Luis, Sigman, Hugo, Perea, Silvio E, Acevedo, Boris E, López-Saura, Pedro
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2009
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2689241/
https://ncbi.nlm.nih.gov/pubmed/19439079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-146
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料